ES8705863A1 - Procedimiento para preparar nuevos 2-arilimidazoles - Google Patents

Procedimiento para preparar nuevos 2-arilimidazoles

Info

Publication number
ES8705863A1
ES8705863A1 ES557240A ES557240A ES8705863A1 ES 8705863 A1 ES8705863 A1 ES 8705863A1 ES 557240 A ES557240 A ES 557240A ES 557240 A ES557240 A ES 557240A ES 8705863 A1 ES8705863 A1 ES 8705863A1
Authority
ES
Spain
Prior art keywords
group
denotes
methoxyphenyl
alkylsulphoximino
methanesulphonyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557240A
Other languages
English (en)
Other versions
ES557240A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8705863A1 publication Critical patent/ES8705863A1/es
Publication of ES557240A0 publication Critical patent/ES557240A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

METODO DE PREPARAR NUEVOS DERIVADOS 2-ARIL-IMIDAZOLES.CONSISTE EN HACER REACCIONAR UN SULFOXIDO DE FORMULA (II) CON ACIDO HIDRAZOICO, EN UNA MEZCLA DE CLORURO DE METILENO Y DIMETILFORMAMIDA, ENTRE 0 Y 40JC PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES DE ADICION DE ACIDOS, SIENDO: AR1 Y AR2 UN GRUPO DE FORMULA (III) O (IV); A Y B CPN AMBOS ATOMOS DE CARBONO REPRESENTA UN GRUPO DE FORMULA (V); R, H O ALQUILO; R1, ALQUILSULFONILO, ALQUILSULFINILO Y OTROS; Y R2, H O ALCOXI. SE UTILIZAN PARA COMBATIR LA PROFILAXIS DE METASTASIS Y DE LA ARTERIOESCLEROSIS.
ES557240A 1985-06-21 1986-12-04 Procedimiento para preparar nuevos 2-arilimidazoles Expired ES8705863A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853522230 DE3522230A1 (de) 1985-06-21 1985-06-21 Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8705863A1 true ES8705863A1 (es) 1987-05-16
ES557240A0 ES557240A0 (es) 1987-05-16

Family

ID=6273829

Family Applications (3)

Application Number Title Priority Date Filing Date
ES556338A Expired ES8800907A1 (es) 1985-06-21 1986-06-20 Procedimiento para preparar nuevos 2-arilimidazoles
ES557241A Expired ES8705864A1 (es) 1985-06-21 1986-12-04 Procedimiento para preparar nuevos 2-aril-imidazoles
ES557240A Expired ES8705863A1 (es) 1985-06-21 1986-12-04 Procedimiento para preparar nuevos 2-arilimidazoles

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES556338A Expired ES8800907A1 (es) 1985-06-21 1986-06-20 Procedimiento para preparar nuevos 2-arilimidazoles
ES557241A Expired ES8705864A1 (es) 1985-06-21 1986-12-04 Procedimiento para preparar nuevos 2-aril-imidazoles

Country Status (12)

Country Link
EP (1) EP0209707A3 (es)
JP (1) JPS62471A (es)
AU (1) AU5893286A (es)
DE (1) DE3522230A1 (es)
DK (1) DK290986A (es)
ES (3) ES8800907A1 (es)
FI (1) FI862623A (es)
GR (1) GR861583B (es)
HU (1) HUT42452A (es)
NO (1) NO862477L (es)
PT (1) PT82789B (es)
ZA (1) ZA864602B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
DE3634066A1 (de) * 1986-10-07 1988-04-21 Boehringer Mannheim Gmbh Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
EP0322149A2 (en) * 1987-12-22 1989-06-28 Eli Lilly And Company Hydrates of an inotropic agent
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
JPH06759B2 (ja) * 1989-09-22 1994-01-05 ファイザー製薬株式会社 新規なベンゾイミダゾール化合物
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JPH05112533A (ja) * 1991-05-08 1993-05-07 Upjohn Co:The イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
US5506361A (en) * 1991-05-08 1996-04-09 Theupjohn Company Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
US5821258A (en) * 1994-12-27 1998-10-13 Mitsui Chemicals, Inc. Phenylbenzimidazole derivatives
AP866A (en) * 1995-08-02 2000-08-17 Newcastle Univ Ventures Limited Benzimidazole compounds.
TR200200972T2 (tr) 1998-11-03 2002-07-22 Basf Aktiengesellschaft İkameli 2-fenilbenzimidazoller, üretimleri ve kullanımları
ATE302758T1 (de) * 1998-11-17 2005-09-15 Abbott Gmbh & Co Kg 2-phenylbenzimidazole und 2-phenylindole, deren herstellung und anwendung
DE19918211A1 (de) 1999-04-22 2000-10-26 Basf Ag Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
RS50939B (sr) 2001-10-19 2010-08-31 Ortho-Mcneil Pharmaceutical Inc. 2-fenil benzimidazoli i imidazo-/4,5/-piridini kao cdsi/chk2 -inhibitori i pomoćna sredstva u hemoterapiji ili terapiji zračenja pri lečenju kancera
DE60326069D1 (de) * 2002-04-05 2009-03-19 Cadila Healthcare Ltd 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
AU2002368133A1 (en) * 2002-07-29 2004-02-16 Shizuoka Coffein Co., Ltd. 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
CA2522562C (en) 2003-04-17 2013-09-03 Janssen Pharmaceutica N.V. 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
PT1718608E (pt) 2004-02-20 2013-08-01 Boehringer Ingelheim Int Inibidores da polimerase viral
ES2362102T3 (es) 2004-06-30 2011-06-28 Janssen Pharmaceutica Nv Eteres de bencimidazol e imidazopiridina sustituidos con arilo como agentes anticáncer.
TWI375673B (en) 2005-04-11 2012-11-01 Abbott Lab 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
US7728026B2 (en) 2005-04-11 2010-06-01 Abbott Laboratories, Inc. 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
US8076365B2 (en) 2005-08-12 2011-12-13 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP1966157B1 (en) 2005-11-15 2010-03-24 Abbott Laboratories Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
MX2008014004A (es) 2006-05-02 2008-11-12 Abbott Lab 1h-benzimidazol-4-carboxamidas sustituidas son inhibidores de parp potentes.
US8067613B2 (en) 2007-07-16 2011-11-29 Abbott Laboratories Benzimidazole poly(ADP ribose)polymerase inhibitors
WO2010083199A1 (en) 2009-01-19 2010-07-22 Abbott Laboratories Benzthiazole inhibitors of poly(adp-ribose)polymerase
RU2013134464A (ru) * 2010-12-24 2015-01-27 Сумитомо Кемикал Компани, Лимитед Конденсированное гетероциклическое соединение и его использование для борьбы с вредителями
BR112015020281B1 (pt) * 2013-02-28 2020-04-22 Sumitomo Chemical Co composto heterocíclico fundido, agente e método para o controle de pragas

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1089853A (en) * 1965-02-25 1967-11-08 Merck & Co Inc Substituted benzimidazoles and compositions containing them
US3669979A (en) * 1967-12-14 1972-06-13 Gaf Corp Novel process for the production of 2-benzothiazolyl-phenol and derivatives thereof employing phosphorus trichloride as a catalyst
DE2305339C3 (de) * 1973-02-03 1980-05-08 Dr. Karl Thomae Gmbh, 7950 Biberach Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
DE2927987A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel
DE2927988A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 8-phenyl-purine, deren herstellung und deren verwendung als arzneimittel
DD147317A1 (de) * 1979-11-23 1981-04-01 Gerald Igel Einrichtung zur elektrischen stimulation des herzens
DE3037464A1 (de) * 1980-10-03 1982-05-19 Dr. Karl Thomae Gmbh, 7950 Biberach 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel
DE3044497A1 (de) * 1980-11-26 1982-06-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neues verfahren zur herstellung von imidazo(4,5-b)pyridinen und -pyrimidinen
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
IL68495A0 (en) * 1982-05-03 1983-07-31 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4515796A (en) * 1983-09-08 1985-05-07 Eli Lilly And Company Certain naphthalenyl imidazo compounds and their pharmaceutical use
DE3340076A1 (de) * 1983-11-05 1985-05-15 Dr. Karl Thomae Gmbh, 7950 Biberach Neue purinderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3346575A1 (de) * 1983-12-23 1985-07-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
GR850426B (es) * 1984-02-24 1985-06-18 Lilly Co Eli

Also Published As

Publication number Publication date
PT82789B (de) 1988-05-17
EP0209707A3 (de) 1989-02-01
DE3522230A1 (de) 1987-01-02
DK290986A (da) 1986-12-22
PT82789A (de) 1986-07-01
NO862477L (no) 1986-12-22
FI862623A0 (fi) 1986-06-19
ES8800907A1 (es) 1987-12-01
NO862477D0 (no) 1986-06-20
ZA864602B (en) 1988-02-24
ES8705864A1 (es) 1987-05-16
ES557240A0 (es) 1987-05-16
JPS62471A (ja) 1987-01-06
AU5893286A (en) 1986-12-24
FI862623A (fi) 1986-12-22
HUT42452A (en) 1987-07-28
EP0209707A2 (de) 1987-01-28
ES556338A0 (es) 1987-12-01
ES557241A0 (es) 1987-05-16
DK290986D0 (da) 1986-06-20
GR861583B (en) 1986-10-21

Similar Documents

Publication Publication Date Title
ES8800907A1 (es) Procedimiento para preparar nuevos 2-arilimidazoles
ES8802517A1 (es) Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
IE892340L (en) 4-oxoquinoline-3-carboxylic acid derivatives, their¹preparation and their use
ES2000185A6 (es) Procedimiento para preparar derivados de acidos piridoncaboxilicos
ES8105298A1 (es) Un procedimiento para la preparacion de imidazol-cianoguani-dinas.
EP0309422A3 (en) New amidino tricycle derivatives
ES8707239A1 (es) Procedimiento para preparar nuevos derivados imidazo.
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8506652A1 (es) Un metodo de preparar dihidrobenzopirrolbenzodiazepinas
EP0202062A3 (en) Quinuclidine derivatives
ES8604165A1 (es) Procedimiento para preparar nuevos bencimidazoles
GB1023793A (en) The manufacture of benzodiazepine derivatives
GR77632B (es)
MX10721A (es) Procedimiento para la preparacion de derivados de imidazol y producto obtenido.
ATE56713T1 (de) 1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ZA925093B (en) 6-oxo-azepinoindol compounds as well as a process and intermediate products for the production thereof,and drugs that contain these compounds
GB1279543A (en) Novel imidazolines, the preparation thereof and compositions containing the same
ES8304934A1 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ATE46147T1 (de) 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
IE820080L (en) Piperazines
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
SE8705196L (sv) Pyrimidinderivat
GB1135947A (en) Novel biologically active derivatives of phenanthridone
GB1195305A (en) Improvements in or relating to Pyrimidine Derivatives and the manufacture thereof
EP0324184A3 (en) 2-amino-1,2,3,4-tetrahydroisoquinoline derivatives, method for their preparation and their use as medicines

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201